FDA Warning Letter — Vitastik

Case 617713 — FEI 3012856522

The FDA took a Warning Letter action against Vitastik on Dec 1, 2021 (Beverly Hills, CA). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Vitastik
Date
Dec 1, 2021
Fiscal Year
2022
Product Type
Drugs
Center
CDER
Location
Beverly Hills, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.